Search

everythinglearnresearchcommunity

for

Search:↓

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Oral Apremilast effectively treats alopecia areata in most patients.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Phosphorus homeopathy treatment led to complete hair regrowth in two Alopecia Areata patients.

Trichoscopy is a useful tool for diagnosing and assessing the severity of alopecia areata.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Deucravacitinib helped a man regrow hair significantly.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.